Why Icon Stock Crushed it on Wednesday

Icon Public (ICLR), a clinical research organization, surged nearly 11% on Wednesday after delivering first-quarter 2026 results that beat analyst expectations. While revenue grew modestly by 0.9% to $2 billion and net income fell 27%, the company's gross bookings jumped 22% year-over-year to $3.3 billion, signaling strong demand for its services in the biotech and pharmaceutical sectors.